Xiaoling Ouyang
Shanghai, 200137, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Luteolin alleviates PCOS by inhibiting AR/STAT3/NLRP3-mediated granulosa cell pyroptosis.
Journal: Journal of ovarian research
Published: September 02, 2025
Jiawei Zaoqi Decoction Attenuates Polycystic Ovary Syndrome by Inhibiting AGE-RAGE-Mediated Cell Senescence of Granulosa Cells.
Journal: Current pharmaceutical design
Published: July 25, 2025
Pathogenesis and treatment of obesity-related polycystic ovary syndrome.
Journal: Journal of ovarian research
Published: May 03, 2025
Hyperoside mitigates PCOS-associated adipogenesis and insulin resistance by regulating NCOA2-mediated PPAR-γ ubiquitination and degradation.
Journal: Life sciences
Published: November 12, 2024
Atractylodin alleviates polycystic ovary syndrome by inhibiting granule cells ferroptosis through pyruvate dehydrogenase kinase 4-mediated JAK-STAT3 pathway.
Journal: International immunopharmacology
Published: July 11, 2024
Direct and economy-wide energy rebound effects in China's transportation sector: a comparative analysis.
Journal: Environmental science and pollution research international
Published: August 02, 2021
Energy efficiency of the industrial sectors in Beijing-Tianjin-Hebei urban agglomeration: does technological gap matter?
Journal: Environmental science and pollution research international
Published: April 13, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026